Other
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease
Abstract
Peripheral artery disease is considered to be a manifestation of systemic atherosclerosis with associated adverse cardiovascular and limb events. Data from previous trials have suggested that patients receiving clopidogrel monotherapy had a lower risk of cardiovascular events than those receiving aspirin. We wanted to compare clopidogrel with ticagrelor, a potent antiplatelet agent, in patients with peripheral artery...
Paper Details
Title
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease
Published Date
Jan 5, 2017
Volume
376
Issue
1
Pages
32 - 40
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History